Cargando…

Phosphatidylethanolamine-binding protein 4 deficiency exacerbates carbon tetrachloride-induced liver fibrosis by regulating the NF-κB signaling pathway

Liver fibrosis is a pathological process which can progress to hepatocirrhosis, even hepatocellular carcinoma. Phosphatidylethanolamine-binding protein 4 (PEBP4) is a secreted protein involved in regulating many molecular pathways, whereas its roles in diseases including hepatic fibrosis remain unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Qianqian, Ling, Yuanyi, Li, Yufei, Qu, Xiaoqin, Shi, Qiaoqing, Zheng, Shuangyan, Li, Yanhong, Huang, Yonghong, Zhou, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478609/
https://www.ncbi.nlm.nih.gov/pubmed/36120358
http://dx.doi.org/10.3389/fphar.2022.964829
_version_ 1784790610119491584
author Luo, Qianqian
Ling, Yuanyi
Li, Yufei
Qu, Xiaoqin
Shi, Qiaoqing
Zheng, Shuangyan
Li, Yanhong
Huang, Yonghong
Zhou, Xiaoyan
author_facet Luo, Qianqian
Ling, Yuanyi
Li, Yufei
Qu, Xiaoqin
Shi, Qiaoqing
Zheng, Shuangyan
Li, Yanhong
Huang, Yonghong
Zhou, Xiaoyan
author_sort Luo, Qianqian
collection PubMed
description Liver fibrosis is a pathological process which can progress to hepatocirrhosis, even hepatocellular carcinoma. Phosphatidylethanolamine-binding protein 4 (PEBP4) is a secreted protein involved in regulating many molecular pathways, whereas its roles in diseases including hepatic fibrosis remain undefined. The nuclear factor-κappa B (NF-κB) signaling pathway has been found to be involved in the development of liver fibrosis. In this study, we generated a hepatocyte-conditional knockout (CKO) mouse model of PEBP4, and explored the potential functions of PEBP4 on liver fibrosis and the NF-κB signaling pathway in a mouse model of carbon tetrachloride (CCl4)-induced liver fibrosis. We demonstrated that PEBP4 CKO aggravated CCl4-triggered liver fibrosis, as evidenced by altered histopathology, an increase in the activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and hydroxyproline (HYP) levels, and more collagen deposition, as well as by enhanced expression of fibrotic markers including α-smooth muscle actin (α-SMA), collagen I and collagen III. Mechanistically, PEBP4 deficiency activated the NF-κB signaling pathway, as indicated by increased phosphorylation of NF-κB p65 and inhibitor protein κB inhibitor-α (IκB-α), and nuclear NF-κB p65 expression in the fibrotic liver. Notably, the NF-κB inhibitor pyrrolidine dithiocarbamate (PDTC) partially blocked the activation of the NF-κB pathway, and reversed the pro-fibrotic effect of PEBP4 deletion in CCl4-treated mice. Together, these results suggest that PEBP4 deficiency results in aggravation of liver fibrosis and activation of the NF-κB signaling pathway, supporting a novel concept that PEBP4 is a crucial player in hepatic fibrosis, but also might be a negative regulator of the NF-κB signaling in liver fibrosis.
format Online
Article
Text
id pubmed-9478609
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94786092022-09-17 Phosphatidylethanolamine-binding protein 4 deficiency exacerbates carbon tetrachloride-induced liver fibrosis by regulating the NF-κB signaling pathway Luo, Qianqian Ling, Yuanyi Li, Yufei Qu, Xiaoqin Shi, Qiaoqing Zheng, Shuangyan Li, Yanhong Huang, Yonghong Zhou, Xiaoyan Front Pharmacol Pharmacology Liver fibrosis is a pathological process which can progress to hepatocirrhosis, even hepatocellular carcinoma. Phosphatidylethanolamine-binding protein 4 (PEBP4) is a secreted protein involved in regulating many molecular pathways, whereas its roles in diseases including hepatic fibrosis remain undefined. The nuclear factor-κappa B (NF-κB) signaling pathway has been found to be involved in the development of liver fibrosis. In this study, we generated a hepatocyte-conditional knockout (CKO) mouse model of PEBP4, and explored the potential functions of PEBP4 on liver fibrosis and the NF-κB signaling pathway in a mouse model of carbon tetrachloride (CCl4)-induced liver fibrosis. We demonstrated that PEBP4 CKO aggravated CCl4-triggered liver fibrosis, as evidenced by altered histopathology, an increase in the activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and hydroxyproline (HYP) levels, and more collagen deposition, as well as by enhanced expression of fibrotic markers including α-smooth muscle actin (α-SMA), collagen I and collagen III. Mechanistically, PEBP4 deficiency activated the NF-κB signaling pathway, as indicated by increased phosphorylation of NF-κB p65 and inhibitor protein κB inhibitor-α (IκB-α), and nuclear NF-κB p65 expression in the fibrotic liver. Notably, the NF-κB inhibitor pyrrolidine dithiocarbamate (PDTC) partially blocked the activation of the NF-κB pathway, and reversed the pro-fibrotic effect of PEBP4 deletion in CCl4-treated mice. Together, these results suggest that PEBP4 deficiency results in aggravation of liver fibrosis and activation of the NF-κB signaling pathway, supporting a novel concept that PEBP4 is a crucial player in hepatic fibrosis, but also might be a negative regulator of the NF-κB signaling in liver fibrosis. Frontiers Media S.A. 2022-09-02 /pmc/articles/PMC9478609/ /pubmed/36120358 http://dx.doi.org/10.3389/fphar.2022.964829 Text en Copyright © 2022 Luo, Ling, Li, Qu, Shi, Zheng, Li, Huang and Zhou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Luo, Qianqian
Ling, Yuanyi
Li, Yufei
Qu, Xiaoqin
Shi, Qiaoqing
Zheng, Shuangyan
Li, Yanhong
Huang, Yonghong
Zhou, Xiaoyan
Phosphatidylethanolamine-binding protein 4 deficiency exacerbates carbon tetrachloride-induced liver fibrosis by regulating the NF-κB signaling pathway
title Phosphatidylethanolamine-binding protein 4 deficiency exacerbates carbon tetrachloride-induced liver fibrosis by regulating the NF-κB signaling pathway
title_full Phosphatidylethanolamine-binding protein 4 deficiency exacerbates carbon tetrachloride-induced liver fibrosis by regulating the NF-κB signaling pathway
title_fullStr Phosphatidylethanolamine-binding protein 4 deficiency exacerbates carbon tetrachloride-induced liver fibrosis by regulating the NF-κB signaling pathway
title_full_unstemmed Phosphatidylethanolamine-binding protein 4 deficiency exacerbates carbon tetrachloride-induced liver fibrosis by regulating the NF-κB signaling pathway
title_short Phosphatidylethanolamine-binding protein 4 deficiency exacerbates carbon tetrachloride-induced liver fibrosis by regulating the NF-κB signaling pathway
title_sort phosphatidylethanolamine-binding protein 4 deficiency exacerbates carbon tetrachloride-induced liver fibrosis by regulating the nf-κb signaling pathway
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478609/
https://www.ncbi.nlm.nih.gov/pubmed/36120358
http://dx.doi.org/10.3389/fphar.2022.964829
work_keys_str_mv AT luoqianqian phosphatidylethanolaminebindingprotein4deficiencyexacerbatescarbontetrachlorideinducedliverfibrosisbyregulatingthenfkbsignalingpathway
AT lingyuanyi phosphatidylethanolaminebindingprotein4deficiencyexacerbatescarbontetrachlorideinducedliverfibrosisbyregulatingthenfkbsignalingpathway
AT liyufei phosphatidylethanolaminebindingprotein4deficiencyexacerbatescarbontetrachlorideinducedliverfibrosisbyregulatingthenfkbsignalingpathway
AT quxiaoqin phosphatidylethanolaminebindingprotein4deficiencyexacerbatescarbontetrachlorideinducedliverfibrosisbyregulatingthenfkbsignalingpathway
AT shiqiaoqing phosphatidylethanolaminebindingprotein4deficiencyexacerbatescarbontetrachlorideinducedliverfibrosisbyregulatingthenfkbsignalingpathway
AT zhengshuangyan phosphatidylethanolaminebindingprotein4deficiencyexacerbatescarbontetrachlorideinducedliverfibrosisbyregulatingthenfkbsignalingpathway
AT liyanhong phosphatidylethanolaminebindingprotein4deficiencyexacerbatescarbontetrachlorideinducedliverfibrosisbyregulatingthenfkbsignalingpathway
AT huangyonghong phosphatidylethanolaminebindingprotein4deficiencyexacerbatescarbontetrachlorideinducedliverfibrosisbyregulatingthenfkbsignalingpathway
AT zhouxiaoyan phosphatidylethanolaminebindingprotein4deficiencyexacerbatescarbontetrachlorideinducedliverfibrosisbyregulatingthenfkbsignalingpathway